Case ReportsMinimally Invasive Diagnosis and Treatment of Endometrial Cancer After LeFort ColpocleisisHarmanli, Oz MD; Celik, Hatice MD; Jones, Keisha A. MD; Yadav, Parul MD; Myers, Tashanna MD Author Information From the Department of Obstetrics and Gynecology, Tufts University School of Medicine, Baystate Medical Center, Springfield, MA. Reprints: Oz Harmanli, MD, Baystate Medical Center, Tufts University School of Medicine, 759 Chestnut St, S-1681, Springfield, MA 01199. E-mail: [email protected]. The authors have declared they have no conflicts of interest. Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.fpmrs.net). Female Pelvic Medicine & Reconstructive Surgery: July/August 2013 - Volume 19 - Issue 4 - p 242-244 doi: 10.1097/SPV.0b013e31828746d7 Buy SDC Metrics AbstractIn Brief Background Endometrial carcinoma is rare after LeFort colpocleisis. Standards for its diagnosis and treatment have not been established. Case A 74-year-old woman presented with postmenopausal bleeding 14 months after LeFort colpocleisis. Here, we describe the use of the colpocleisis channels in our novel 2-stage approach. In the first stage, endometrial carcinoma was diagnosed with vaginohysteroscopy and dilatation and curettage via the channels. In the second stage, the cancer was optimally treated with total robotic hysterectomy, bilateral salpingo-oophorectomy, and lymph node dissection. Assistance and specimen retrieval were achieved through the vaginal channels. The patient recovered without compromise to the pelvic floor. Conclusions Endometrial cancer after LeFort colpocleisis can be diagnosed and treated with minimally invasive approaches without disrupting the colpocleisis or the pelvic floor support. Endometrial cancer after LeFort colpocleisis can be diagnosed and treated with minimally invasive approaches without disrupting the colpocleisis and the pelvic floor support. Copyright © 2013 Wolters Kluwer Health, Inc. All rights reserved.